Combination Chemotherapy in Treating Young Patients With Langerhans Cell Histiocytosis

Completed · Not applicable

Conditions studied: Childhood Langerhans Cell Histiocytosis

In brief

RATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of Langerhans cell histiocytosis, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may be an effective treatment for Langerhans cell histiocytosis. PURPOSE: This randomized clinical trial is studying combination chemotherapy to see how well it works in treating young patients with Langerhans cell histiocytosis.

Key facts

Study ID
NCT00276757
Run by
Histiocyte Society
People needed
376
Starts
2001-04-01
Expected to finish
2013-06-01
Last updated by the study team
2014-01-10

Who can join

Age: any, up to 17. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.